LORI WINK: Open Payments
NPI 1295279750 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 21 payments from 8 companies in 2025. Trend: 2023 $6,348 · 2024 $609 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma Global Development | 5 | $218 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $141 |
| Biogen, Inc. | 4 | $107 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $53 |
| ABBVIE INC. | 1 | $34 |
| Astellas Pharma US Inc | 1 | $27 |
| Evofem Biosciences, Inc. | 2 | $25 |
| Exeltis, USA Inc. | 1 | $21 |
Products named: Veozah, ZURZUVAE, LO LOESTRIN FE, Lynkuet, Phexxi, SLYND.
Industry payments across TX — which companies pay providers there.
